InMode (INMD) Other Non-Current Liabilities (2018 - 2025)
InMode (INMD) posted quarterly Other Non-Current Liabilities of $4.4 million for Q4 2025, up 32.18% year-on-year from $3.4 million in Q4 2024, and up 32.18% on a QoQ basis from $3.4 million in Q4 2024.
InMode (INMD) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends
InMode (INMD) has reported Other Non-Current Liabilities for 8 consecutive years, with $4.4 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 32.18% year-over-year to $4.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.4 million (up 32.18% YoY) and the FY2025 annual result came in at $4.4 million, up 32.18% from the prior year.
- Other Non-Current Liabilities improved to $4.4 million in Q4 2025 per INMD's latest filing, from $3.4 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for INMD reached as high as $4.8 million in Q4 2021 and fell as low as $303000.0 in Q4 2022.
- A 5-year average of $2.9 million and a median of $3.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 93.73% — and 2023, when it surged 361.72%.
- Year by year, Other Non-Current Liabilities stood at $4.8 million in 2021, then tumbled by 93.73% to $303000.0 in 2022, then surged by 361.72% to $1.4 million in 2023, then jumped by 139.89% to $3.4 million in 2024, then jumped by 32.18% to $4.4 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $4.4 million, $3.4 million, and $1.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | 303,000.00 |
| Dec 31, 2021 | 4.83 Mn |
| Dec 31, 2020 | 2.91 Mn |
| Dec 31, 2019 | 1.49 Mn |
| Dec 31, 2018 | 771,000.00 |